Calcium phosphate stone morphology can reliably predict distal renal tubular acidosis. 2015

Arnaud Dessombz, and Emmanuel Letavernier, and Jean-Philippe Haymann, and Dominique Bazin, and Michel Daudon
Centre National de la Recherche, Laboratoire de Physique des Solides, Université Paris-11, Orsay, France; Institut National de la Santé et de la Recherche Médicale, Unités Mixtes de Recherche 1138, Centre de Recherche des Cordeliers, Laboratoire de Physiopathologie Orale Moléculaire, Equipe Berdal, Université Paris-5, Université Paris-6, Université Paris-7, Paris, France. Electronic address: arnaud.dessombz@crc.jussieu.fr.

OBJECTIVE Calcium stones represent 85% to 90% of all urinary calculi, including various crystalline compositions and etiological conditions. Calcium phosphate accounts for 10% to 15% of cases. These stones are mainly related to 3 groups of risk factors, including calcium or phosphate metabolism disturbance, renal acidification defects and urinary tract infection. Identifying the stone etiology often requires extensive metabolic evaluation. We assessed whether stone analysis including morphological typing in addition to stone composition could be a valuable help for diagnosis. METHODS Of 60,564 stones analyzed by morphological examination and infrared spectroscopy at our laboratory 6,439 (10.6%) were mainly composed of carbapatite. Of these stone 1,093 patients were included in study who had an available etiological diagnosis and stones containing at least 70% of calcium phosphate without struvite. RESULTS Of the 1,093 calcium phosphate stones 12.8% showed a peculiar morphology termed IVa2, characterized by a smooth aspect and a glazed brown-yellow appearance with tiny cracks. IVa2 morphology was observed in 96.1% of stones associated with inherited distal renal tubular acidosis. In contrast, the other stones of similar composition but different morphology were related to distal renal tubular acidosis in only 3.9% of cases. In addition, IVa2 stones were found in 65% of calcium phosphate stone formers associated with Sjögren syndrome and in 35% of calcium phosphate stones in patients with medullary sponge kidney. These 2 conditions are related to a mild to moderate distal acidification defect. CONCLUSIONS Identifying IVa2 stone morphology is clinically relevant because it should prompt clinicians to search for complete or incomplete distal acidosis and initiate specific therapy to decrease recurrence.

UI MeSH Term Description Entries
D007669 Kidney Calculi Stones in the KIDNEY, usually formed in the urine-collecting area of the kidney (KIDNEY PELVIS). Their sizes vary and most contains CALCIUM OXALATE. Kidney Stones,Renal Calculi,Nephrolith,Renal Calculus,Calculi, Kidney,Calculi, Renal,Calculus, Kidney,Calculus, Renal,Kidney Calculus,Kidney Stone,Stone, Kidney,Stones, Kidney
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D002130 Calcium Phosphates Calcium salts of phosphoric acid. These compounds are frequently used as calcium supplements. Phosphates, Calcium
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000141 Acidosis, Renal Tubular A group of genetic disorders of the KIDNEY TUBULES characterized by the accumulation of metabolically produced acids with elevated plasma chloride, hyperchloremic metabolic ACIDOSIS. Defective renal acidification of URINE (proximal tubules) or low renal acid excretion (distal tubules) can lead to complications such as HYPOKALEMIA, hypercalcinuria with NEPHROLITHIASIS and NEPHROCALCINOSIS, and RICKETS. Renal Tubular Acidosis,Renal Tubular Acidosis, Type I,Renal Tubular Acidosis, Type II,Type I Renal Tubular Acidosis,Type II Renal Tubular Acidosis,Acidosis, Renal Tubular, Type I,Acidosis, Renal Tubular, Type II,Autosomal Dominant Distal Renal Tubular Acidosis,Classic Distal Renal Tubular Acidosis,Distal Renal Tubular Acidosis,Proximal Renal Tubular Acidosis,RTA, Classic Type,RTA, Distal Type, Autosomal Dominant,RTA, Gradient Type,RTA, Proximal Type,Renal Tubular Acidosis 1,Renal Tubular Acidosis I,Renal Tubular Acidosis II,Renal Tubular Acidosis, Distal, Autosomal Dominant,Renal Tubular Acidosis, Proximal,Renal Tubular Acidosis, Proximal, with Ocular Abnormalities,Classic Type RTA,Classic Type RTAs,Gradient Type RTA,Gradient Type RTAs,Proximal Type RTA,Proximal Type RTAs,RTAs, Classic Type,RTAs, Gradient Type,RTAs, Proximal Type
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face

Related Publications

Arnaud Dessombz, and Emmanuel Letavernier, and Jean-Philippe Haymann, and Dominique Bazin, and Michel Daudon
October 1989, Danish medical bulletin,
Arnaud Dessombz, and Emmanuel Letavernier, and Jean-Philippe Haymann, and Dominique Bazin, and Michel Daudon
June 1989, British journal of urology,
Arnaud Dessombz, and Emmanuel Letavernier, and Jean-Philippe Haymann, and Dominique Bazin, and Michel Daudon
July 1980, Annals of internal medicine,
Arnaud Dessombz, and Emmanuel Letavernier, and Jean-Philippe Haymann, and Dominique Bazin, and Michel Daudon
March 2020, World journal of urology,
Arnaud Dessombz, and Emmanuel Letavernier, and Jean-Philippe Haymann, and Dominique Bazin, and Michel Daudon
April 2007, Kidney international,
Arnaud Dessombz, and Emmanuel Letavernier, and Jean-Philippe Haymann, and Dominique Bazin, and Michel Daudon
May 1978, The Journal of the Association of Physicians of India,
Arnaud Dessombz, and Emmanuel Letavernier, and Jean-Philippe Haymann, and Dominique Bazin, and Michel Daudon
April 2004, Current opinion in pediatrics,
Arnaud Dessombz, and Emmanuel Letavernier, and Jean-Philippe Haymann, and Dominique Bazin, and Michel Daudon
September 1980, The Journal of the Association of Physicians of India,
Arnaud Dessombz, and Emmanuel Letavernier, and Jean-Philippe Haymann, and Dominique Bazin, and Michel Daudon
May 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Arnaud Dessombz, and Emmanuel Letavernier, and Jean-Philippe Haymann, and Dominique Bazin, and Michel Daudon
June 1976, Wiener medizinische Wochenschrift (1946),
Copied contents to your clipboard!